Active Surveillance Patients International: [ Ссылка ]
The Active Surveillor: [ Ссылка ]
0:24 What is Gleason 6 prostate cancer?
2:22 If it doesn't metastasize, why is it called cancer?
4:26 Clinical study examines whether Gleason 6 prostate cancer metastasizes
6:56 Spread is something that occurs before the prostate is removed, not after
7:55 Can Gleason 6 prostate cancer transform into a higher grade?
9:31 Is 50% of all prostate cancer Gleason 6?
9:44 How can a patient know for sure that their grade is Gleason 6?
10:42 Are active surveillance patients less likely to die of prostate cancer?
11:15 How should a patient handle being advised to treat Gleason 6?
13:19 Can active surveillance continue indefinitely?
14:15 At what level is a PSA considered potentially concerning?
15:06 How often does a second pathology result in a new Gleason grade?
16:17 Is there any context in which a Gleason 6 patient should seek treatment?
17:49 Alex's conclusions
Donate to PCRI: [ Ссылка ]
For more information, visit [ Ссылка ]
Don't know your stage? Take the quiz: visit [ Ссылка ]
To learn more about prostate cancer, visit [ Ссылка ]
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
